These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6167818)

  • 1. Cellular electrophysiology of clofilium, a new antifibrillatory agent, in normal and ischemic canine Purkinje fibers.
    Steinberg MI; Sullivan ME; Wiest SA; Rockhold FW; Molloy BB
    J Cardiovasc Pharmacol; 1981; 3(4):881-95. PubMed ID: 6167818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clofilium on ischemic subendocardial Purkinje fibers 1 day postinfarction.
    Gough WB; Hu D; el-Sherif N
    J Am Coll Cardiol; 1988 Feb; 11(2):431-7. PubMed ID: 3339184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tocainide on Purkinje fibers from normal and infarcted ventricular tissues.
    Dersham GH; Han J; Cameron JS; O'Connell DP
    J Electrocardiol; 1986 Oct; 19(4):355-9. PubMed ID: 3098883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential response of normal and ischaemic Purkinje fibres to clofilium, d-sotalol and bretylium.
    Gough WB; el-Sherif N
    Cardiovasc Res; 1989 Jun; 23(6):554-9. PubMed ID: 2590928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of therapeutic concentrations of procainamide on transmembrane action potentials of normal and infarct zone Purkinje fibers and ventricular muscle cells.
    Dangman KH; Miura DS
    J Cardiovasc Pharmacol; 1989 Jun; 13(6):846-52. PubMed ID: 2484078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological characterization of BRL-32872 in canine Purkinje fiber and ventricular muscle. Effect on early after-depolarizations and repolarization dispersion.
    Faivre JF; Forest MC; Gout B; Bril A
    Eur J Pharmacol; 1999 Oct; 383(2):215-22. PubMed ID: 10585537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological effects of cyclic GMP on canine cardiac Purkinje fibers.
    Mehegan JP; Muir WW; Unverferth DV; Fertel RH; McGuirk SM
    J Cardiovasc Pharmacol; 1985; 7(1):30-5. PubMed ID: 2580147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the potassium channel activator, BRL 34915, on the action potential characteristics of canine cardiac Purkinje fibers.
    Bril A; Man RY
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1090-6. PubMed ID: 2359018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of lidocaine on transmembrane potentials of subendocardial Purkinje fibers surviving in infarcted canine hearts.
    Allen JD; Brennan FJ; Wit AL
    Circ Res; 1978 Sep; 43(3):470-81. PubMed ID: 679429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiarrhythmic drugs on the cycle length-dependent action potential duration in dog Purkinje and ventricular muscle fibers.
    Varro A; Nakaya Y; Elharrar V; Surawicz B
    J Cardiovasc Pharmacol; 1986; 8(1):178-85. PubMed ID: 2419682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
    Damiano BP; Stump GL; Yagel SK
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.
    Ikeda N; Singh BN; Davis LD; Hauswirth O
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):303-10. PubMed ID: 3968315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular electrophysiology of the new antiarrhythmic agent recainam (Wy-42,362) in canine cardiac Purkinje fibers.
    Colatsky TJ; Bird LB; Jurkiewicz NK; Wendt RL
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):435-44. PubMed ID: 2438506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers.
    Nattel S; Zeng FD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):283-91. PubMed ID: 6707943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of epinephrine on the electrophysiologic properties of Purkinje fibers surviving myocardial infarction.
    Cameron JS; Dersham GH; Han J
    Am Heart J; 1982 Sep; 104(3):551-60. PubMed ID: 7113895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early afterdepolarizations produced by d,l-sotalol and clofilium.
    Patterson E; Scherlag BJ; Lazzara R
    J Cardiovasc Electrophysiol; 1997 Jun; 8(6):667-78. PubMed ID: 9209968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propafenone slows conduction and produces a nonuniform recovery of excitability between Purkinje and ventricular muscle fibers.
    Tamargo J
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):203-7. PubMed ID: 7692158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents.
    Orth PM; Hesketh JC; Mak CK; Yang Y; Lin S; Beatch GN; Ezrin AM; Fedida D
    Cardiovasc Res; 2006 Jun; 70(3):486-96. PubMed ID: 16545351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of antiarrhythmic agents on post-pause repolarization in cardiac Purkinje fibres.
    Wyse KR; Bursill JA; Campbell TJ
    Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):825-9. PubMed ID: 8911721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological effects of bethanidine sulfate on canine cardiac Purkinje fibers and ventricular muscle cells.
    Dangman KH; Miura DS
    J Cardiovasc Pharmacol; 1985; 7(1):50-8. PubMed ID: 2580150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.